Risk of Hospitalization for Severe Hypersensitivity (Including Severe Skin Reactions) in Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments

NCT01086319 · clinicaltrials.gov ↗

COMPLETED

Status

113505

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Sponsor

AstraZeneca

Collaborators

[object Object]
[object Object]